Skip to content

Bromhexine / Metaproterenol

Published: July 27, 2026Updated: August 28, 2026

Bromhexine/Metaproterenol is a combination medication that addresses both mucus clearance and airway obstruction in respiratory conditions. Bromhexine acts as a mucolytic to thin and loosen viscous secretions, while Metaproterenol is a beta-2 agonist bronchodilator that relaxes airway smooth muscle. This combination is typically prescribed for patients with respiratory conditions involving both excessive mucus production and bronchospasm.

Quick summary

A dual-action respiratory medication combining a mucolytic agent with a bronchodilator to improve breathing and mucus clearance.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 28, 2026Editorial policy

Key facts at a glance

RxNorm
821588
Generic
Bromhexine / Metaproterenol
Class
multi-ingredient
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

This medication is used to treat respiratory conditions characterized by both excessive mucus production and bronchoconstriction, including chronic bronchitis, COPD exacerbations, and other conditions where chest congestion and difficulty breathing coexist.

Bromhexine breaks down mucopolysaccharide fibers in bronchial secretions, thinning and loosening mucus for easier clearance. Metaproterenol stimulates beta-2 adrenergic receptors in bronchial smooth muscle, causing relaxation and bronchodilation that allows air to flow more freely through the airways.

May cause tremor, tachycardia, or nervousness due to the bronchodilator component. Should be used with caution in patients with cardiovascular conditions, diabetes, or hyperthyroidism. Not typically used as first-line therapy and is generally reserved for patients not adequately controlled on single-agent therapy. Effectiveness may vary between formulations.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 28, 2026. · Read our editorial policy